(MCHC), mean corpuscular volume (MCV), platelet (PLT), red blood cell (RBC), red cell distribution width (RDW) or white blood cell (WBC) values were outside the normal laboratory reference range. For electrolyte panels, we considered the panel to be abnormal if any of the chloride (Cl), potassium (K), and sodium (Na) were outside of the normal laboratory reference range. All EP results were from clinical chemistry analyzers only. The reuse potential of this dataset can allow other jurisdictions in Canada to compare their redundant repeat testing in their hospital settings with this dataset as a benchmark. This article was submitted via another Elsevier journal as a co-submission ("Inappropriate repeat testing of complete blood count (CBC) and electrolytes in inpatients from Alberta, Canada" [1] ), and readers should refer to the cosubmission article for interpretation of the results.
© 
Data description
Secondary laboratory data was collected from CLDR, which contains laboratory data from all three LIS for the province of Alberta in Canada (Millennium, Sunquest, Meditech). Test volume, number of tests repeated within the 2018 calendar year, number of tests that were repeated within a 24-h period that was previously normal or abnormal (as defined by the laboratory reference range) for CBC and electrolyte panels by test in all inpatient and emergency room encounters across Alberta, matched by patient PHN, are summarized in Table 1 . Complete blood count panels were considered to be abnormal if at least one of the following had an abnormal test result: Hct, Hgb, MCHC, MCV, PLT, RBC, RDW, or WBC. Electrolyte panels were considered to be abnormal if at least one of the following had an abnormal test result: chloride, potassium, sodium. The number and percentage of tests repeated, and tests repeated that were previously abnormal or normal were reported in Table 1 for each of the Laboratory Information Systems in Alberta.
Experimental design, materials, and methods
Laboratory data was retrieved and aggregated by an independent Alberta Health Services data analyst with access to CLDR, which contained laboratory data performed in all settings across Alberta. All laboratory tests performed within the province were captured by Millennium, Sunquest and Meditech LIS. The following secondary laboratory data for electrolyte panel (EP) and complete blood count (CBC) test panels performed in emergency room (ER) and inpatient settings between January 1 to December 31 in 2018 were collected: total test panel volume, total number of test panels repeated, number of test panels repeated within the 24 hour period, test result, date of testing, time of test, and patient Provincial Health Number (PHN). For each patient who received a test panel of interest, the PHN was temporarily used as a grouping variable to match subsequent tests to the same patient. There was no retrieval or collection of patient name and other individually identifying information by the researchers. The unique PHN was permanently removed upon completion of data retrieval. The first time a test was recorded per patient was defined as the "index test". If the same test panel was performed within a 24-h period following the index test for the patient, data for the repeated test panel was also collected. The index test was defined as "normal" or "abnormal" according to established laboratory normal values and laboratory test reference ranges. For CBCs, we considered a result to be abnormal if any of the Hct, Hgb, MCHV, MCV, PLT, RBC, RDW, or WBC values were outside of the laboratory reference range. For electrolyte panels, we considered a result to be abnormal if any of the sodium, potassium, or chloride were outside of the laboratory reference range. To calculate the percentage of the repeated previously normal or abnormal results, the numerator was defined as the number of tests repeated within a 24 hour period that were previously normal or abnormal, whereas the denominator was defined as the total number of tests repeated within the study period of one year. All EP results were from clinical chemistry analyzers only. This article was submitted via another Elsevier journal as a co-submission, and readers should refer to the co-submission article for interpretation of the results [1] .
Value of the Data
This dataset can be useful for other jurisdictions to assess laboratory utilization appropriateness in their own hospital settings Laboratorians, ordering physicians, patients, experts in laboratory utilization management can benefit from this data Results from this data and its associated article can assist policy makers in implementing utilization initiatives and update clinical practice guidelines to reduce redundant testing while optimizing patient care Additional value of this dataset include using it as a benchmark to compare with other Canadian jurisdictions who order CBCs and EPs in their inpatient and emergency room settings. This dataset can also be used as a template to assess testing appropriateness in other commonly ordered laboratory tests 
